CORDIS · 827942 · H2020

BioBalanced Feasibility study for Bioapplications – BioBalanced Farm probiotic

Coordinator: UAB BIOAPPLICATIONS (LT)

A rapid emergence of resistant bacteria occurs worldwide, endangering the efficacy of antibiotics, which have transformed medicine and saved millions of lives. The antibiotic resistance crisis has been attributed to the overuse and misuse of these medications. 700 000 patients die annually as a result of infections caused by antibiotic resistant bacteria. Due to a growing demand to substitute medicine and hazardous chemical usage in agriculture, Bioapplications developed the BioBalanced Farm Probiotic – a unique probiotics blend, which is misted in the facility, naturally excludes pathogenic …

EU contribution
€50k
Total cost
€71k
Period
2018-07-01 → 2018-12-31
Framework
Horizon 2020 (2014–2020)
Funding scheme
SME-1
Call
H2020-EIC-SMEInst-2018-2020
Status
CLOSED

About Horizon 2020 (2014–2020)

Horizon 2020 was the EU's flagship research and innovation programme for 2014–2020, with a budget of around €77 billion. It bundled FP7's strands with the EIT and the Competitiveness and Innovation Programme, introduced a stronger societal-challenge orientation, and pushed the funding logic toward closer-to-market innovation. New calls closed in 2020 but funded projects continued through 2024.

Co-funding: the European Union contributes €50k toward a total project budget of €71k — a funding rate of 70%, with the remainder covered by the consortium partners. The project runs over approximately 0.5 years from 2018-07-01 to 2018-12-31.

Full record on CORDIS — partners, deliverables, publications, news.

Open on cordis.europa.eu → Grant DOI ↗

Frequently asked questions

Who funds this research project?
This project is funded by the European Union through the Horizon 2020 (2014–2020) programme, under the SME-1 funding scheme.
What is the EU contribution?
The European Commission contributes €50k toward a total project budget of €71k.
Which EU programme funds it?
The project is funded under Horizon 2020 (2014–2020), call H2020-EIC-SMEInst-2018-2020.
Who coordinates the project?
The project is coordinated by UAB BIOAPPLICATIONS (LT).
What is the project timeline?
The project runs from 2018-07-01 to 2018-12-31 — approximately 0.5 years.
Where can I find the full project record?
The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 827942.